Your browser doesn't support javascript.
loading
Drogas potenciadoras para la búsqueda de la perfección / Human enhancement drugs and the pursuit of perfection
McVeigh, Jim; Evans-Brown, Michael; Bellis, Mark A.
Affiliation
  • McVeigh, Jim; Liverpool John Moores University. Faculty of Health and Applied Social Science. Liverpool. United Kingdom
  • Evans-Brown, Michael; Liverpool John Moores University. Faculty of Health and Applied Social Science. Liverpool. United Kingdom
  • Bellis, Mark A; Liverpool John Moores University. Faculty of Health and Applied Social Science. Liverpool. United Kingdom
Adicciones (Palma de Mallorca) ; 24(3): 185-190, jul.-sept. 2012. tab
Article in English | IBECS | ID: ibc-101638
Responsible library: ES1.1
Localization: BNCS
RESUMEN
Hay un gran interés hacia serie de medicamentos usados para la mejora o potenciación de distintos aspectos de la condición humana, lo que les convierte en un nuevo problema de salud pública al que se ha prestado poca atención hasta ahora. En un intento por ser más fuertes, felices o inteligentes, o para parecer más delgados, más jóvenes o más bellos, la gente está recurriendo a diversos productos farmacéuticos. La amplia disponibilidad de fármacos con potencial para mejorar las capacidades humanas, la apariencia y las habilidades ha generado una nueva y cada vez mayor audiencia de usuarios. A diferencia de los usuarios de drogas como la heroína, la cocaína, etc., estos usuarios de este tipo de sustancias no necesariamente se perciben a sí mismos como ‘usuarios de drogas’. Las personas atraídas por estos medicamentos pueden tener un escaso o ningún conocimiento sobre los peligros físicos o psicológicos asociados con estas sustancias o sobre su potencial adictivo. Además de los potentes efectos de muchos de estos medicamentos, existen considerables riesgos asociados a la naturaleza clandestina del mercado. El creciente número de medicamentos no evaluados, prohibidos o adulterados y la falta de garantías y de calidad en el proceso de fabricación ilegal ha dado lugar a serios problemas y muertes. La facilidad con que los productos farmacéuticos pueden ser fabricados y distribuidos, junto con los importantes beneficios que se pueden conseguir desde el mercado ilegal, se ha traducido en un creciente desafío para los responsables de las políticas y los sistemas de salud en muchos países. Esta editorial tiene como objetivo dar a conocer esta nueva situación asociada a estas drogas potenciadoras y a ofrecer una breve visión de alguna de ellas y de los riesgos asociados (AU)
ABSTRACT
The emerging threat to public health posed by the use of human enhancement drugs has remained largely unrecognised. In attempts to become stronger, happier or smarter, or to look thinner, younger or more beautiful, people are turning to a diverse range of pharmaceuticals. The widespread availability of drugs with the potential to improve human attributes, appearance and abilities has generated a new and growing audience of users. Unlike users of drugs such as heroin, cocaine etc, users of human enhancement drugs do not necessarily perceive themselves as ‘drug users’. Those attracted to these drugs may have little or no knowledge or understanding of the physical or psychological harm associated with these substances or their potential for addiction. In addition to the potent effects of many human enhancement drugs, there are considerable risks associated to the clandestine nature of the market. The growing number of untested, banned or adulterated drugs and the lack of safeguards and quality assurance in the illicit manufacturing process has resulted in serious harms and fatalities. The ease with which pharmaceuticals can be manufactured and distributed, combined with the significant profits that can be made from the illicit market, has resulted in a growing challenge for policy makers and health systems in many countries. This editorial aims to raise awareness of this emerging drugs situation and provide a brief overview of some of the drugs and their associated risks (AU)
Subject(s)
Search on Google
Collection: National databases / Spain Health context: Sustainable Health Agenda for the Americas / SDG3 - Health and Well-Being / SDG3 -Target 3.5 Prevention and treatment of consumption of psychoactive substances Health problem: Goal 5: Medicines, vaccines and health technologies / Target 3.5: Prevention and treatment of consumption of psychoactive substances / Opioid Abuse Database: IBECS Main subject: Substance-Related Disorders / Drug Synergism / Anabolic Agents Limits: Humans Language: English Journal: Adicciones (Palma de Mallorca) Year: 2012 Document type: Article Institution/Affiliation country: Liverpool John Moores University/United Kingdom
Search on Google
Collection: National databases / Spain Health context: Sustainable Health Agenda for the Americas / SDG3 - Health and Well-Being / SDG3 -Target 3.5 Prevention and treatment of consumption of psychoactive substances Health problem: Goal 5: Medicines, vaccines and health technologies / Target 3.5: Prevention and treatment of consumption of psychoactive substances / Opioid Abuse Database: IBECS Main subject: Substance-Related Disorders / Drug Synergism / Anabolic Agents Limits: Humans Language: English Journal: Adicciones (Palma de Mallorca) Year: 2012 Document type: Article Institution/Affiliation country: Liverpool John Moores University/United Kingdom
...